Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders
Identifieur interne : 003F02 ( Main/Exploration ); précédent : 003F01; suivant : 003F03Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders
Auteurs : Regina Katzenschlager [Royaume-Uni] ; Adriana Cardozo [Espagne] ; M. Rosario Avila Cobo [Espagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-10.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Classification, Homme.
English descriptors
- KwdEn :
- Age of Onset, Aged, Aged, 80 and over, Antiparkinson Agents (therapeutic use), Atypical, Classification, Cross-Sectional Studies, Demography, Diagnosis, Diagnosis, Differential, Ethnic Groups, Europe, Europe (epidemiology), Europe (ethnology), Female, Human, Humans, Levodopa (therapeutic use), Male, Middle Aged, Movement Disorders (classification), Movement Disorders (complications), Movement Disorders (diagnosis), Movement Disorders (drug therapy), Neurologic Examination, Outpatient Clinics, Hospital, Parkinsonian Disorders (classification), Parkinsonian Disorders (complications), Parkinsonian Disorders (diagnosis), Parkinsonian Disorders (drug therapy), Parkinsonism, Prevalence, Prospective Studies, Referral and Consultation, Retrospective Studies, Statistics, Nonparametric, Symptomatology, atypical parkinsonism, clinical diagnostic criteria.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- geographic , epidemiology : Europe.
- geographic , ethnology : Europe.
- classification : Movement Disorders, Parkinsonian Disorders.
- complications : Movement Disorders, Parkinsonian Disorders.
- diagnosis : Movement Disorders, Parkinsonian Disorders.
- drug therapy : Movement Disorders, Parkinsonian Disorders.
- Age of Onset, Aged, Aged, 80 and over, Cross-Sectional Studies, Demography, Diagnosis, Differential, Ethnic Groups, Female, Humans, Male, Middle Aged, Neurologic Examination, Outpatient Clinics, Hospital, Prevalence, Prospective Studies, Referral and Consultation, Retrospective Studies, Statistics, Nonparametric.
Abstract
In view of reports on high frequencies of atypical parkinsonism from different parts of the world and in non‐white communities in the United Kingdom, we have prospectively surveyed 1,000 consecutive patients with parkinsonism presenting to two European tertiary referral centres for movement disorders (London, UK, and Barcelona, Spain). The aims of our study were to assess in a cross‐sectional, prospective manner the proportion of patients who could not be classified diagnostically, to identify the factors precluding classification, and to determine which diagnostic measures would increase the rate of classifiable cases. Diagnoses were established using published clinical diagnostic criteria for Parkinson's disease (PD) and for other conditions associated with parkinsonism. Twenty‐nine patients in London and 25 in Barcelona were initially considered unclassifiable; nine could be classified after further investigations. Levodopa (L‐dopa) responsiveness was found to have a pivotal role in establishing a clinical diagnosis in previously unclassifiable patients: In those 45 patients who remained unclassifiable, failure to respond to L‐dopa without other exclusion criteria for PD was the most common finding in each centre. Our results show that 4.0 to 5.0% of parkinsonian patients presenting to specialist clinics in Western Europe cannot be categorised using currently available clinical diagnostic criteria for parkinsonian syndromes. Prolonged follow‐up and neuropathological diagnosis will be needed to determine whether all these cases represent atypical presentations of established clinico‐pathological entities or whether some represent unrecognised new disorders. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10523
Affiliations:
- Espagne, Royaume-Uni
- Angleterre, Grand Londres
- Londres
- National Hospital for Neurology and Neurosurgery
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000291
- to stream Istex, to step Curation: 000291
- to stream Istex, to step Checkpoint: 002831
- to stream PubMed, to step Corpus: 003671
- to stream PubMed, to step Curation: 003671
- to stream PubMed, to step Checkpoint: 003598
- to stream Ncbi, to step Merge: 000B93
- to stream Ncbi, to step Curation: 000B93
- to stream Ncbi, to step Checkpoint: 000B93
- to stream Main, to step Merge: 005B24
- to stream PascalFrancis, to step Corpus: 002358
- to stream PascalFrancis, to step Curation: 000963
- to stream PascalFrancis, to step Checkpoint: 002284
- to stream Main, to step Merge: 005E30
- to stream Main, to step Curation: 003F02
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders</title>
<author><name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
</author>
<author><name sortKey="Cardozo, Adriana" sort="Cardozo, Adriana" uniqKey="Cardozo A" first="Adriana" last="Cardozo">Adriana Cardozo</name>
</author>
<author><name sortKey="Avila Cobo, M Rosario" sort="Avila Cobo, M Rosario" uniqKey="Avila Cobo M" first="M. Rosario" last="Avila Cobo">M. Rosario Avila Cobo</name>
</author>
<author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:77027BC1452267D906FEC3E3B5242A364A7B9917</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10523</idno>
<idno type="url">https://api.istex.fr/document/77027BC1452267D906FEC3E3B5242A364A7B9917/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000291</idno>
<idno type="wicri:Area/Istex/Curation">000291</idno>
<idno type="wicri:Area/Istex/Checkpoint">002831</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Katzenschlager R:unclassifiable:parkinsonism:in</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14534915</idno>
<idno type="wicri:Area/PubMed/Corpus">003671</idno>
<idno type="wicri:Area/PubMed/Curation">003671</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003598</idno>
<idno type="wicri:Area/Ncbi/Merge">000B93</idno>
<idno type="wicri:Area/Ncbi/Curation">000B93</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B93</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Katzenschlager R:unclassifiable:parkinsonism:in</idno>
<idno type="wicri:Area/Main/Merge">005B24</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0095570</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002358</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000963</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002284</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Katzenschlager R:unclassifiable:parkinsonism:in</idno>
<idno type="wicri:Area/Main/Merge">005E30</idno>
<idno type="wicri:Area/Main/Curation">003F02</idno>
<idno type="wicri:Area/Main/Exploration">003F02</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders</title>
<author><name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cardozo, Adriana" sort="Cardozo, Adriana" uniqKey="Cardozo A" first="Adriana" last="Cardozo">Adriana Cardozo</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Institut Clinic de Malalties del Sistema Nerviós, Hospital Clinic Universitari, School of Medicine, University of Barcelona</wicri:regionArea>
<wicri:noRegion>University of Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Avila Cobo, M Rosario" sort="Avila Cobo, M Rosario" uniqKey="Avila Cobo M" first="M. Rosario" last="Avila Cobo">M. Rosario Avila Cobo</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Institut Clinic de Malalties del Sistema Nerviós, Hospital Clinic Universitari, School of Medicine, University of Barcelona</wicri:regionArea>
<wicri:noRegion>University of Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Institut Clinic de Malalties del Sistema Nerviós, Hospital Clinic Universitari, School of Medicine, University of Barcelona</wicri:regionArea>
<wicri:noRegion>University of Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-10">2003-10</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="1123">1123</biblScope>
<biblScope unit="page" to="1131">1131</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">77027BC1452267D906FEC3E3B5242A364A7B9917</idno>
<idno type="DOI">10.1002/mds.10523</idno>
<idno type="ArticleID">MDS10523</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age of Onset</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Atypical</term>
<term>Classification</term>
<term>Cross-Sectional Studies</term>
<term>Demography</term>
<term>Diagnosis</term>
<term>Diagnosis, Differential</term>
<term>Ethnic Groups</term>
<term>Europe</term>
<term>Europe (epidemiology)</term>
<term>Europe (ethnology)</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Movement Disorders (classification)</term>
<term>Movement Disorders (complications)</term>
<term>Movement Disorders (diagnosis)</term>
<term>Movement Disorders (drug therapy)</term>
<term>Neurologic Examination</term>
<term>Outpatient Clinics, Hospital</term>
<term>Parkinsonian Disorders (classification)</term>
<term>Parkinsonian Disorders (complications)</term>
<term>Parkinsonian Disorders (diagnosis)</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonism</term>
<term>Prevalence</term>
<term>Prospective Studies</term>
<term>Referral and Consultation</term>
<term>Retrospective Studies</term>
<term>Statistics, Nonparametric</term>
<term>Symptomatology</term>
<term>atypical parkinsonism</term>
<term>clinical diagnostic criteria</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Europe</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="ethnology" xml:lang="en"><term>Europe</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Age of Onset</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cross-Sectional Studies</term>
<term>Demography</term>
<term>Diagnosis, Differential</term>
<term>Ethnic Groups</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Outpatient Clinics, Hospital</term>
<term>Prevalence</term>
<term>Prospective Studies</term>
<term>Referral and Consultation</term>
<term>Retrospective Studies</term>
<term>Statistics, Nonparametric</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Atypique</term>
<term>Classification</term>
<term>Diagnostic</term>
<term>Europe</term>
<term>Homme</term>
<term>Parkinsonisme</term>
<term>Symptomatologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Classification</term>
<term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In view of reports on high frequencies of atypical parkinsonism from different parts of the world and in non‐white communities in the United Kingdom, we have prospectively surveyed 1,000 consecutive patients with parkinsonism presenting to two European tertiary referral centres for movement disorders (London, UK, and Barcelona, Spain). The aims of our study were to assess in a cross‐sectional, prospective manner the proportion of patients who could not be classified diagnostically, to identify the factors precluding classification, and to determine which diagnostic measures would increase the rate of classifiable cases. Diagnoses were established using published clinical diagnostic criteria for Parkinson's disease (PD) and for other conditions associated with parkinsonism. Twenty‐nine patients in London and 25 in Barcelona were initially considered unclassifiable; nine could be classified after further investigations. Levodopa (L‐dopa) responsiveness was found to have a pivotal role in establishing a clinical diagnosis in previously unclassifiable patients: In those 45 patients who remained unclassifiable, failure to respond to L‐dopa without other exclusion criteria for PD was the most common finding in each centre. Our results show that 4.0 to 5.0% of parkinsonian patients presenting to specialist clinics in Western Europe cannot be categorised using currently available clinical diagnostic criteria for parkinsonian syndromes. Prolonged follow‐up and neuropathological diagnosis will be needed to determine whether all these cases represent atypical presentations of established clinico‐pathological entities or whether some represent unrecognised new disorders. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
<orgName><li>National Hospital for Neurology and Neurosurgery</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Katzenschlager, Regina" sort="Katzenschlager, Regina" uniqKey="Katzenschlager R" first="Regina" last="Katzenschlager">Regina Katzenschlager</name>
</region>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name>
</country>
<country name="Espagne"><noRegion><name sortKey="Cardozo, Adriana" sort="Cardozo, Adriana" uniqKey="Cardozo A" first="Adriana" last="Cardozo">Adriana Cardozo</name>
</noRegion>
<name sortKey="Avila Cobo, M Rosario" sort="Avila Cobo, M Rosario" uniqKey="Avila Cobo M" first="M. Rosario" last="Avila Cobo">M. Rosario Avila Cobo</name>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F02 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F02 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:77027BC1452267D906FEC3E3B5242A364A7B9917 |texte= Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders }}
This area was generated with Dilib version V0.6.23. |